Get the Stockscreener App
4.77
0.63%
-0.03
After Hours:
4.78
0.01
+0.21%
Trisalus Life Sciences Inc stock is traded at $4.77, with a volume of 55,029.
It is down -0.63% in the last 24 hours and down -18.74% over the past month.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
See More
Previous Close:
$4.80
Open:
$4.87
24h Volume:
55,029
Relative Volume:
0.34
Market Cap:
$238.33M
Revenue:
$15.33M
Net Income/Loss:
$-40.19M
P/E Ratio:
-2.7223
EPS:
-1.7522
Net Cash Flow:
-
1W Performance:
+1.92%
1M Performance:
-18.74%
6M Performance:
+30.68%
1Y Performance:
-14.97%
1-Day Range:
$4.735
$4.87
1-Week Range:
$4.38
$4.875
52-Week Range:
$3.42
$7.95
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Name
Trisalus Life Sciences Inc
Sector
Industry
Phone
415 336 8917
Address
6272 WEST 91ST AVENUE, WESTMINSTER
Compare TLSI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
4.77 | 239.83M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-25 | Initiated | Lake Street | Buy |
| Dec-17-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-11-24 | Initiated | ROTH MKM | Buy |
| Oct-25-24 | Initiated | Northland Capital | Outperform |
| Sep-16-24 | Initiated | Oppenheimer | Outperform |
| May-30-24 | Initiated | Canaccord Genuity | Buy |
View All
Trisalus Life Sciences Inc Stock (TLSI) Latest News
TriSalus Life Sciences swaps board members - BizWest
Aug Rallies: Is TriSalus Life Sciences Inc Equity Warrants growth already priced inCEO Change & Safe Entry Trade Signal Reports - baoquankhu1.vn
Downgrade Watch: What are the risks of holding TriSalus Life Sciences Inc Equity WarrantJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn
Investment Review: Is TriSalus Life Sciences Inc Equity Warrant a top pick in the sectorGDP Growth & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Decliners Report: Why is TriSalus Life Sciences Inc stock going upOil Prices & Risk Managed Investment Strategies - baoquankhu1.vn
TriSalus Life Sciences appoints Michael Stansky to board of directors By Investing.com - Investing.com South Africa
Trisalus Life Sciences appoints veteran healthcare investor Michael Stansky to its board of directors - marketscreener.com
TriSalus Life Sciences appoints Michael Stansky to board of directors - Investing.com
TriSalus Life Sciences Announces New Board Appointment - TipRanks
40-year healthcare dealmaker joins cancer-tech firm TriSalus board - Stock Titan
TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors - marketscreener.com
TriSalus Life Sciences, Inc. Announces Board and Board Committee Changes - marketscreener.com
TriSalus Life Sciences (NASDAQ:TLSI) Stock Rating Lowered by Wall Street Zen - MarketBeat
Financial Comparison: Phibro Animal Health (NASDAQ:PAHC) & TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
Swing Trade: Why is TriSalus Life Sciences Inc stock going upQuarterly Trade Summary & Weekly Top Gainers Alerts - baoquankhu1.vn
Trend Report: Is TriSalus Life Sciences Inc Equity Warrant forming a bullish divergence2025 Major Catalysts & Safe Entry Zone Identification - baoquankhu1.vn
Published on: 2026-02-02 19:55:53 - baoquankhu1.vn
Aug Selloffs: Can TriSalus Life Sciences Inc Equity Warrant lead its sector in growthJuly 2025 Breakouts & Risk Managed Investment Strategies - baoquankhu1.vn
TriSalus Life Sciences (NASDAQ:TLSI) Upgraded at Wall Street Zen - MarketBeat
Head to Head Survey: Semperit Ag Hld (OTCMKTS:SEIGY) & TriSalus Life Sciences (NASDAQ:TLSI) - Defense World
Macro Review: What is TriSalus Life Sciences Inc Equity Warrants P E ratio telling usWeekly Volume Report & Comprehensive Market Scan Insights - baoquankhu1.vn
Aug Spikes: Does TriSalus Life Sciences Inc have pricing power2025 Short Interest & Reliable Volume Spike Alerts - baoquankhu1.vn
Aug PreEarnings: Will TriSalus Life Sciences Inc benefit from rate cutsJuly 2025 Movers & Reliable Intraday Trade Alerts - baoquankhu1.vn
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Trisalus life sciences CEO buys $50,302 in stock - MSN
Is TriSalus Life Sciences Inc. Equity Warrant forming a bullish divergenceDividend Hike & Low Risk High Reward Trade Ideas - Bollywood Helpline
What catalysts could drive TriSalus Life Sciences Inc. Equity Warrant stock higherWeekly Trading Summary & Advanced Technical Signal Analysis - Bollywood Helpline
Published on: 2026-01-18 10:38:25 - baoquankhu1.vn
Rate Hike: Is TriSalus Life Sciences Inc stock a value trapRecession Risk & AI Driven Stock Price Forecasts - baoquankhu1.vn
TriSalus Life Sciences, Inc. (TLSI) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Does TriSalus Life Sciences Inc. have strong EBITDA marginsStock Correlation Metrics & AI-Based Insights for Consistent Profits - bollywoodhelpline.com
TriSalus Life Sciences reports 60% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Gap Down: Does TriSalus Life Sciences Inc have strong EBITDA marginsShort Setup & Consistent Profit Trading Strategies - baoquankhu1.vn
Oncology company TriSalus boosts sales in fourth quarter - bizwest.com
Jobs Data: Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrendJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - baoquankhu1.vn
TriSalus Life Sciences reports 60% revenue growth in Q4 2025 - Investing.com
Cancer-focused medical tech firm’s sales jump 60% in latest quarter - Stock Titan
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance - bdtonline.com
Is TriSalus Life Sciences Inc Equity Warrant in a long term uptrendDip Buying & High Conviction Trade Alerts - baoquankhu1.vn
What risks investors should watch in TriSalus Life Sciences Inc. Equity Warrant stockWeekly Trade Summary & Short-Term High Return Strategies - ulpravda.ru
TriSalus Life Sciences (NASDAQ:TLSIW) Stock Price Up 13.9% – Should You Buy? - Defense World
Can Sumeet Industries Limited (514211) Maintain Its ValuationEquity Performance Review & Use Our Sector Rotation Strategy for Gains - bollywoodhelpline.com
Trisalus Life Sciences CFO buys $33,900 in common stock - MSN
Is TriSalus Life Sciences Inc. stock vulnerable to regulatory risksJuly 2025 Big Picture & Community Verified Trade Signals - Улправда
How geopolitical risks impact CDP stockPortfolio Update Report & Consistent Profit Focused Trading Strategies - ulpravda.ru
Will National Research Corporation stock deliver shareholder valueGap Down & Expert Approved Momentum Ideas - ulpravda.ru
Is NeuroSense Therapeutics Ltd. stock resilient to inflationGlobal Markets & Weekly High Momentum Picks - ulpravda.ru
Will TriSalus Life Sciences Inc. Equity Warrant stock deliver long term returns2025 Short Interest & Consistent Profit Trading Strategies - Улправда
Is TriSalus Life Sciences Inc. Equity Warrant stock safe for conservative investorsJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - Улправда
Will TriSalus Life Sciences Inc. stock keep outperforming rivalsJuly 2025 Setups & Community Verified Swing Trade Signals - Улправда
Will TriSalus Life Sciences Inc. Equity Warrant stock maintain momentum in 2025 - Улправда
Trisalus Life Sciences Inc Stock (TLSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):